-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Maintains Buy on AbbVie, Raises Price Target to $276

Benzinga·07/10/2026 18:01:33
Listen to the news
B of A Securities analyst Geoff Meacham maintains AbbVie (NYSE:ABBV) with a Buy and raises the price target from $234 to $276.